nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethoxazole—ALB—Auranofin—psoriatic arthritis	0.336	0.416	CbGbCtD
Sulfamethoxazole—ALB—Prednisone—psoriatic arthritis	0.107	0.132	CbGbCtD
Sulfamethoxazole—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0553	0.0685	CbGbCtD
Sulfamethoxazole—ALB—Methotrexate—psoriatic arthritis	0.0536	0.0665	CbGbCtD
Sulfamethoxazole—CYP2C8—Dexamethasone—psoriatic arthritis	0.0516	0.0639	CbGbCtD
Sulfamethoxazole—CYP3A4—Triamcinolone—psoriatic arthritis	0.0419	0.0519	CbGbCtD
Sulfamethoxazole—CYP2C9—Dexamethasone—psoriatic arthritis	0.036	0.0446	CbGbCtD
Sulfamethoxazole—CYP3A4—Betamethasone—psoriatic arthritis	0.0359	0.0446	CbGbCtD
Sulfamethoxazole—CYP3A4—Prednisolone—psoriatic arthritis	0.0355	0.044	CbGbCtD
Sulfamethoxazole—CYP3A4—Prednisone—psoriatic arthritis	0.0335	0.0415	CbGbCtD
Sulfamethoxazole—CYP3A4—Dexamethasone—psoriatic arthritis	0.0209	0.0259	CbGbCtD
Sulfamethoxazole—Diarrhoea—Auranofin—psoriatic arthritis	0.00107	0.00555	CcSEcCtD
Sulfamethoxazole—Vascular purpura—Triamcinolone—psoriatic arthritis	0.00105	0.00541	CcSEcCtD
Sulfamethoxazole—Vomiting—Auranofin—psoriatic arthritis	0.000997	0.00516	CcSEcCtD
Sulfamethoxazole—Rash—Auranofin—psoriatic arthritis	0.000989	0.00512	CcSEcCtD
Sulfamethoxazole—Dermatitis—Auranofin—psoriatic arthritis	0.000988	0.00511	CcSEcCtD
Sulfamethoxazole—Purpura—Triamcinolone—psoriatic arthritis	0.000971	0.00502	CcSEcCtD
Sulfamethoxazole—Nausea—Auranofin—psoriatic arthritis	0.000932	0.00482	CcSEcCtD
Sulfamethoxazole—Oliguria—Methotrexate—psoriatic arthritis	0.000924	0.00478	CcSEcCtD
Sulfamethoxazole—Glossitis—Methotrexate—psoriatic arthritis	0.000924	0.00478	CcSEcCtD
Sulfamethoxazole—Hepatic enzyme increased—Methotrexate—psoriatic arthritis	0.0009	0.00466	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Prednisolone—psoriatic arthritis	0.000862	0.00446	CcSEcCtD
Sulfamethoxazole—Vascular purpura—Prednisone—psoriatic arthritis	0.000826	0.00428	CcSEcCtD
Sulfamethoxazole—Aplastic anaemia—Methotrexate—psoriatic arthritis	0.000799	0.00414	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Triamcinolone—psoriatic arthritis	0.000793	0.0041	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Methylprednisolone—psoriatic arthritis	0.000791	0.00409	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Prednisolone—psoriatic arthritis	0.000769	0.00398	CcSEcCtD
Sulfamethoxazole—Purpura—Prednisone—psoriatic arthritis	0.000767	0.00397	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Methylprednisolone—psoriatic arthritis	0.000719	0.00372	CcSEcCtD
Sulfamethoxazole—Infestation—Methylprednisolone—psoriatic arthritis	0.000719	0.00372	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Triamcinolone—psoriatic arthritis	0.000707	0.00366	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Methylprednisolone—psoriatic arthritis	0.000705	0.00365	CcSEcCtD
Sulfamethoxazole—Photosensitivity—Methotrexate—psoriatic arthritis	0.000704	0.00364	CcSEcCtD
Sulfamethoxazole—Polyuria—Methotrexate—psoriatic arthritis	0.000704	0.00364	CcSEcCtD
Sulfamethoxazole—Dermatitis exfoliative—Methotrexate—psoriatic arthritis	0.000655	0.00339	CcSEcCtD
Sulfamethoxazole—Hallucination—Methylprednisolone—psoriatic arthritis	0.000643	0.00333	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Dexamethasone—psoriatic arthritis	0.000641	0.00332	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Betamethasone—psoriatic arthritis	0.000641	0.00332	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.000635	0.00328	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Prednisone—psoriatic arthritis	0.000626	0.00324	CcSEcCtD
Sulfamethoxazole—Eye disorder—Methylprednisolone—psoriatic arthritis	0.000604	0.00312	CcSEcCtD
Sulfamethoxazole—Neutropenia—Prednisone—psoriatic arthritis	0.000598	0.00309	CcSEcCtD
Sulfamethoxazole—Hallucination—Dexamethasone—psoriatic arthritis	0.000584	0.00302	CcSEcCtD
Sulfamethoxazole—Hallucination—Betamethasone—psoriatic arthritis	0.000584	0.00302	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.000583	0.00302	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.000582	0.00301	CcSEcCtD
Sulfamethoxazole—Ataxia—Methotrexate—psoriatic arthritis	0.000581	0.00301	CcSEcCtD
Sulfamethoxazole—Depression—Prednisone—psoriatic arthritis	0.000568	0.00294	CcSEcCtD
Sulfamethoxazole—Mental disorder—Methylprednisolone—psoriatic arthritis	0.000566	0.00293	CcSEcCtD
Sulfamethoxazole—Malnutrition—Methylprednisolone—psoriatic arthritis	0.000562	0.00291	CcSEcCtD
Sulfamethoxazole—Angioedema—Prednisolone—psoriatic arthritis	0.00056	0.0029	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.000558	0.00289	CcSEcCtD
Sulfamethoxazole—Toxic epidermal necrolysis—Methotrexate—psoriatic arthritis	0.000556	0.00288	CcSEcCtD
Sulfamethoxazole—Vertigo—Prednisolone—psoriatic arthritis	0.00055	0.00285	CcSEcCtD
Sulfamethoxazole—Eye disorder—Dexamethasone—psoriatic arthritis	0.000549	0.00284	CcSEcCtD
Sulfamethoxazole—Eye disorder—Betamethasone—psoriatic arthritis	0.000549	0.00284	CcSEcCtD
Sulfamethoxazole—Convulsion—Prednisolone—psoriatic arthritis	0.000531	0.00275	CcSEcCtD
Sulfamethoxazole—Eosinophilia—Methotrexate—psoriatic arthritis	0.000529	0.00274	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Methotrexate—psoriatic arthritis	0.000524	0.00271	CcSEcCtD
Sulfamethoxazole—Angioedema—Triamcinolone—psoriatic arthritis	0.000515	0.00266	CcSEcCtD
Sulfamethoxazole—Angioedema—Methylprednisolone—psoriatic arthritis	0.000514	0.00266	CcSEcCtD
Sulfamethoxazole—Hallucination—Prednisone—psoriatic arthritis	0.000509	0.00263	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Methotrexate—psoriatic arthritis	0.000507	0.00262	CcSEcCtD
Sulfamethoxazole—Vertigo—Triamcinolone—psoriatic arthritis	0.000506	0.00262	CcSEcCtD
Sulfamethoxazole—Vertigo—Methylprednisolone—psoriatic arthritis	0.000505	0.00261	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000503	0.0026	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.0005	0.00259	CcSEcCtD
Sulfamethoxazole—Neutropenia—Methotrexate—psoriatic arthritis	0.000499	0.00258	CcSEcCtD
Sulfamethoxazole—Cough—Triamcinolone—psoriatic arthritis	0.000492	0.00254	CcSEcCtD
Sulfamethoxazole—Convulsion—Triamcinolone—psoriatic arthritis	0.000488	0.00253	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.000487	0.00252	CcSEcCtD
Sulfamethoxazole—Convulsion—Methylprednisolone—psoriatic arthritis	0.000487	0.00252	CcSEcCtD
Sulfamethoxazole—Myalgia—Triamcinolone—psoriatic arthritis	0.00048	0.00248	CcSEcCtD
Sulfamethoxazole—Pneumonia—Methotrexate—psoriatic arthritis	0.000479	0.00248	CcSEcCtD
Sulfamethoxazole—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000479	0.00248	CcSEcCtD
Sulfamethoxazole—Myalgia—Methylprednisolone—psoriatic arthritis	0.000479	0.00248	CcSEcCtD
Sulfamethoxazole—Eye disorder—Prednisone—psoriatic arthritis	0.000478	0.00247	CcSEcCtD
Sulfamethoxazole—Infestation—Methotrexate—psoriatic arthritis	0.000476	0.00246	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Methotrexate—psoriatic arthritis	0.000476	0.00246	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000475	0.00246	CcSEcCtD
Sulfamethoxazole—Depression—Methotrexate—psoriatic arthritis	0.000475	0.00246	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.000472	0.00244	CcSEcCtD
Sulfamethoxazole—Renal failure—Methotrexate—psoriatic arthritis	0.000468	0.00242	CcSEcCtD
Sulfamethoxazole—Angioedema—Betamethasone—psoriatic arthritis	0.000467	0.00242	CcSEcCtD
Sulfamethoxazole—Angioedema—Dexamethasone—psoriatic arthritis	0.000467	0.00242	CcSEcCtD
Sulfamethoxazole—Stomatitis—Methotrexate—psoriatic arthritis	0.000464	0.0024	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Prednisone—psoriatic arthritis	0.000462	0.00239	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00046	0.00238	CcSEcCtD
Sulfamethoxazole—Vertigo—Dexamethasone—psoriatic arthritis	0.000459	0.00238	CcSEcCtD
Sulfamethoxazole—Vertigo—Betamethasone—psoriatic arthritis	0.000459	0.00238	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000459	0.00237	CcSEcCtD
Sulfamethoxazole—Insomnia—Prednisolone—psoriatic arthritis	0.000452	0.00234	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00045	0.00233	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00045	0.00233	CcSEcCtD
Sulfamethoxazole—Mental disorder—Prednisone—psoriatic arthritis	0.000448	0.00232	CcSEcCtD
Sulfamethoxazole—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000446	0.00231	CcSEcCtD
Sulfamethoxazole—Malnutrition—Prednisone—psoriatic arthritis	0.000445	0.0023	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000444	0.0023	CcSEcCtD
Sulfamethoxazole—Convulsion—Dexamethasone—psoriatic arthritis	0.000443	0.00229	CcSEcCtD
Sulfamethoxazole—Convulsion—Betamethasone—psoriatic arthritis	0.000443	0.00229	CcSEcCtD
Sulfamethoxazole—Myalgia—Dexamethasone—psoriatic arthritis	0.000435	0.00225	CcSEcCtD
Sulfamethoxazole—Myalgia—Betamethasone—psoriatic arthritis	0.000435	0.00225	CcSEcCtD
Sulfamethoxazole—Hepatitis—Methotrexate—psoriatic arthritis	0.000427	0.00221	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000422	0.00218	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Methotrexate—psoriatic arthritis	0.000419	0.00217	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000419	0.00217	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000418	0.00216	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000417	0.00216	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000417	0.00216	CcSEcCtD
Sulfamethoxazole—Insomnia—Triamcinolone—psoriatic arthritis	0.000416	0.00215	CcSEcCtD
Sulfamethoxazole—Insomnia—Methylprednisolone—psoriatic arthritis	0.000415	0.00215	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00041	0.00212	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000409	0.00212	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000409	0.00212	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000409	0.00211	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000409	0.00211	CcSEcCtD
Sulfamethoxazole—Angioedema—Prednisone—psoriatic arthritis	0.000407	0.00211	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000405	0.0021	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000404	0.00209	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000404	0.00209	CcSEcCtD
Sulfamethoxazole—Vertigo—Prednisone—psoriatic arthritis	0.0004	0.00207	CcSEcCtD
Sulfamethoxazole—Eye disorder—Methotrexate—psoriatic arthritis	0.000399	0.00207	CcSEcCtD
Sulfamethoxazole—Tinnitus—Methotrexate—psoriatic arthritis	0.000399	0.00206	CcSEcCtD
Sulfamethoxazole—Anorexia—Dexamethasone—psoriatic arthritis	0.000398	0.00206	CcSEcCtD
Sulfamethoxazole—Anorexia—Betamethasone—psoriatic arthritis	0.000398	0.00206	CcSEcCtD
Sulfamethoxazole—Urticaria—Prednisolone—psoriatic arthritis	0.000397	0.00206	CcSEcCtD
Sulfamethoxazole—Fatigue—Triamcinolone—psoriatic arthritis	0.000396	0.00205	CcSEcCtD
Sulfamethoxazole—Fatigue—Methylprednisolone—psoriatic arthritis	0.000396	0.00205	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Methotrexate—psoriatic arthritis	0.000386	0.002	CcSEcCtD
Sulfamethoxazole—Convulsion—Prednisone—psoriatic arthritis	0.000386	0.002	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000385	0.00199	CcSEcCtD
Sulfamethoxazole—Chills—Methotrexate—psoriatic arthritis	0.000384	0.00199	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00038	0.00197	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00038	0.00197	CcSEcCtD
Sulfamethoxazole—Arthralgia—Prednisone—psoriatic arthritis	0.000379	0.00196	CcSEcCtD
Sulfamethoxazole—Myalgia—Prednisone—psoriatic arthritis	0.000379	0.00196	CcSEcCtD
Sulfamethoxazole—Insomnia—Betamethasone—psoriatic arthritis	0.000377	0.00195	CcSEcCtD
Sulfamethoxazole—Insomnia—Dexamethasone—psoriatic arthritis	0.000377	0.00195	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000376	0.00195	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000375	0.00194	CcSEcCtD
Sulfamethoxazole—Mental disorder—Methotrexate—psoriatic arthritis	0.000374	0.00194	CcSEcCtD
Sulfamethoxazole—Malnutrition—Methotrexate—psoriatic arthritis	0.000372	0.00193	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000368	0.00191	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000367	0.0019	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Betamethasone—psoriatic arthritis	0.000367	0.0019	CcSEcCtD
Sulfamethoxazole—Urticaria—Triamcinolone—psoriatic arthritis	0.000365	0.00189	CcSEcCtD
Sulfamethoxazole—Urticaria—Methylprednisolone—psoriatic arthritis	0.000365	0.00189	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000364	0.00188	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000363	0.00188	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000363	0.00188	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000363	0.00188	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Betamethasone—psoriatic arthritis	0.000363	0.00188	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00036	0.00186	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00036	0.00186	CcSEcCtD
Sulfamethoxazole—Fatigue—Dexamethasone—psoriatic arthritis	0.00036	0.00186	CcSEcCtD
Sulfamethoxazole—Fatigue—Betamethasone—psoriatic arthritis	0.00036	0.00186	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Prednisone—psoriatic arthritis	0.000356	0.00184	CcSEcCtD
Sulfamethoxazole—Skin disorder—Prednisone—psoriatic arthritis	0.000353	0.00183	CcSEcCtD
Sulfamethoxazole—Anorexia—Prednisone—psoriatic arthritis	0.000346	0.00179	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000341	0.00177	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000341	0.00177	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000339	0.00175	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000338	0.00175	CcSEcCtD
Sulfamethoxazole—Vertigo—Methotrexate—psoriatic arthritis	0.000334	0.00173	CcSEcCtD
Sulfamethoxazole—Leukopenia—Methotrexate—psoriatic arthritis	0.000333	0.00172	CcSEcCtD
Sulfamethoxazole—Urticaria—Betamethasone—psoriatic arthritis	0.000331	0.00172	CcSEcCtD
Sulfamethoxazole—Urticaria—Dexamethasone—psoriatic arthritis	0.000331	0.00172	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000331	0.00171	CcSEcCtD
Sulfamethoxazole—Dizziness—Prednisolone—psoriatic arthritis	0.000331	0.00171	CcSEcCtD
Sulfamethoxazole—Asthenia—Triamcinolone—psoriatic arthritis	0.00033	0.00171	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00033	0.00171	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Betamethasone—psoriatic arthritis	0.00033	0.00171	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Betamethasone—psoriatic arthritis	0.00033	0.00171	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00033	0.00171	CcSEcCtD
Sulfamethoxazole—Asthenia—Methylprednisolone—psoriatic arthritis	0.000329	0.0017	CcSEcCtD
Sulfamethoxazole—Insomnia—Prednisone—psoriatic arthritis	0.000329	0.0017	CcSEcCtD
Sulfamethoxazole—Pruritus—Triamcinolone—psoriatic arthritis	0.000325	0.00168	CcSEcCtD
Sulfamethoxazole—Cough—Methotrexate—psoriatic arthritis	0.000325	0.00168	CcSEcCtD
Sulfamethoxazole—Pruritus—Methylprednisolone—psoriatic arthritis	0.000325	0.00168	CcSEcCtD
Sulfamethoxazole—Convulsion—Methotrexate—psoriatic arthritis	0.000322	0.00167	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Prednisone—psoriatic arthritis	0.00032	0.00166	CcSEcCtD
Sulfamethoxazole—Arthralgia—Methotrexate—psoriatic arthritis	0.000317	0.00164	CcSEcCtD
Sulfamethoxazole—Myalgia—Methotrexate—psoriatic arthritis	0.000317	0.00164	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Prednisone—psoriatic arthritis	0.000316	0.00163	CcSEcCtD
Sulfamethoxazole—Rash—Prednisolone—psoriatic arthritis	0.000315	0.00163	CcSEcCtD
Sulfamethoxazole—Dermatitis—Prednisolone—psoriatic arthritis	0.000315	0.00163	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000315	0.00163	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000314	0.00162	CcSEcCtD
Sulfamethoxazole—Fatigue—Prednisone—psoriatic arthritis	0.000313	0.00162	CcSEcCtD
Sulfamethoxazole—Headache—Prednisolone—psoriatic arthritis	0.000313	0.00162	CcSEcCtD
Sulfamethoxazole—Dizziness—Triamcinolone—psoriatic arthritis	0.000304	0.00157	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000304	0.00157	CcSEcCtD
Sulfamethoxazole—Dizziness—Methylprednisolone—psoriatic arthritis	0.000303	0.00157	CcSEcCtD
Sulfamethoxazole—Asthenia—Betamethasone—psoriatic arthritis	0.000299	0.00155	CcSEcCtD
Sulfamethoxazole—Asthenia—Dexamethasone—psoriatic arthritis	0.000299	0.00155	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000298	0.00154	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000297	0.00154	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000297	0.00154	CcSEcCtD
Sulfamethoxazole—Nausea—Prednisolone—psoriatic arthritis	0.000297	0.00154	CcSEcCtD
Sulfamethoxazole—Pruritus—Dexamethasone—psoriatic arthritis	0.000295	0.00153	CcSEcCtD
Sulfamethoxazole—Pruritus—Betamethasone—psoriatic arthritis	0.000295	0.00153	CcSEcCtD
Sulfamethoxazole—Skin disorder—Methotrexate—psoriatic arthritis	0.000295	0.00153	CcSEcCtD
Sulfamethoxazole—Vomiting—Triamcinolone—psoriatic arthritis	0.000292	0.00151	CcSEcCtD
Sulfamethoxazole—Vomiting—Methylprednisolone—psoriatic arthritis	0.000292	0.00151	CcSEcCtD
Sulfamethoxazole—Rash—Triamcinolone—psoriatic arthritis	0.00029	0.0015	CcSEcCtD
Sulfamethoxazole—Dermatitis—Triamcinolone—psoriatic arthritis	0.00029	0.0015	CcSEcCtD
Sulfamethoxazole—Anorexia—Methotrexate—psoriatic arthritis	0.000289	0.0015	CcSEcCtD
Sulfamethoxazole—Rash—Methylprednisolone—psoriatic arthritis	0.000289	0.0015	CcSEcCtD
Sulfamethoxazole—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000289	0.0015	CcSEcCtD
Sulfamethoxazole—Urticaria—Prednisone—psoriatic arthritis	0.000289	0.00149	CcSEcCtD
Sulfamethoxazole—Headache—Triamcinolone—psoriatic arthritis	0.000288	0.00149	CcSEcCtD
Sulfamethoxazole—Headache—Methylprednisolone—psoriatic arthritis	0.000287	0.00149	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Prednisone—psoriatic arthritis	0.000287	0.00149	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Prednisone—psoriatic arthritis	0.000287	0.00149	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Betamethasone—psoriatic arthritis	0.000285	0.00148	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000285	0.00148	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000277	0.00143	CcSEcCtD
Sulfamethoxazole—Dizziness—Dexamethasone—psoriatic arthritis	0.000276	0.00143	CcSEcCtD
Sulfamethoxazole—Dizziness—Betamethasone—psoriatic arthritis	0.000276	0.00143	CcSEcCtD
Sulfamethoxazole—Insomnia—Methotrexate—psoriatic arthritis	0.000275	0.00142	CcSEcCtD
Sulfamethoxazole—Nausea—Triamcinolone—psoriatic arthritis	0.000273	0.00141	CcSEcCtD
Sulfamethoxazole—Nausea—Methylprednisolone—psoriatic arthritis	0.000273	0.00141	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Methotrexate—psoriatic arthritis	0.000271	0.0014	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Prednisone—psoriatic arthritis	0.000268	0.00139	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Methotrexate—psoriatic arthritis	0.000267	0.00138	CcSEcCtD
Sulfamethoxazole—Vomiting—Betamethasone—psoriatic arthritis	0.000265	0.00137	CcSEcCtD
Sulfamethoxazole—Vomiting—Dexamethasone—psoriatic arthritis	0.000265	0.00137	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Methotrexate—psoriatic arthritis	0.000264	0.00137	CcSEcCtD
Sulfamethoxazole—Rash—Betamethasone—psoriatic arthritis	0.000263	0.00136	CcSEcCtD
Sulfamethoxazole—Rash—Dexamethasone—psoriatic arthritis	0.000263	0.00136	CcSEcCtD
Sulfamethoxazole—Dermatitis—Dexamethasone—psoriatic arthritis	0.000263	0.00136	CcSEcCtD
Sulfamethoxazole—Dermatitis—Betamethasone—psoriatic arthritis	0.000263	0.00136	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000262	0.00136	CcSEcCtD
Sulfamethoxazole—Fatigue—Methotrexate—psoriatic arthritis	0.000262	0.00136	CcSEcCtD
Sulfamethoxazole—Headache—Dexamethasone—psoriatic arthritis	0.000261	0.00135	CcSEcCtD
Sulfamethoxazole—Headache—Betamethasone—psoriatic arthritis	0.000261	0.00135	CcSEcCtD
Sulfamethoxazole—Asthenia—Prednisone—psoriatic arthritis	0.000261	0.00135	CcSEcCtD
Sulfamethoxazole—Pruritus—Prednisone—psoriatic arthritis	0.000257	0.00133	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Prednisone—psoriatic arthritis	0.000249	0.00129	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000248	0.00129	CcSEcCtD
Sulfamethoxazole—Nausea—Betamethasone—psoriatic arthritis	0.000248	0.00128	CcSEcCtD
Sulfamethoxazole—Nausea—Dexamethasone—psoriatic arthritis	0.000248	0.00128	CcSEcCtD
Sulfamethoxazole—Urticaria—Methotrexate—psoriatic arthritis	0.000241	0.00125	CcSEcCtD
Sulfamethoxazole—Dizziness—Prednisone—psoriatic arthritis	0.00024	0.00124	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Methotrexate—psoriatic arthritis	0.00024	0.00124	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Methotrexate—psoriatic arthritis	0.00024	0.00124	CcSEcCtD
Sulfamethoxazole—Vomiting—Prednisone—psoriatic arthritis	0.000231	0.0012	CcSEcCtD
Sulfamethoxazole—Rash—Prednisone—psoriatic arthritis	0.000229	0.00119	CcSEcCtD
Sulfamethoxazole—Dermatitis—Prednisone—psoriatic arthritis	0.000229	0.00118	CcSEcCtD
Sulfamethoxazole—Headache—Prednisone—psoriatic arthritis	0.000228	0.00118	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000224	0.00116	CcSEcCtD
Sulfamethoxazole—Asthenia—Methotrexate—psoriatic arthritis	0.000218	0.00113	CcSEcCtD
Sulfamethoxazole—Nausea—Prednisone—psoriatic arthritis	0.000216	0.00112	CcSEcCtD
Sulfamethoxazole—Pruritus—Methotrexate—psoriatic arthritis	0.000215	0.00111	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Methotrexate—psoriatic arthritis	0.000208	0.00108	CcSEcCtD
Sulfamethoxazole—Dizziness—Methotrexate—psoriatic arthritis	0.000201	0.00104	CcSEcCtD
Sulfamethoxazole—Vomiting—Methotrexate—psoriatic arthritis	0.000193	0.000999	CcSEcCtD
Sulfamethoxazole—Rash—Methotrexate—psoriatic arthritis	0.000191	0.000991	CcSEcCtD
Sulfamethoxazole—Dermatitis—Methotrexate—psoriatic arthritis	0.000191	0.00099	CcSEcCtD
Sulfamethoxazole—Headache—Methotrexate—psoriatic arthritis	0.00019	0.000985	CcSEcCtD
Sulfamethoxazole—Nausea—Methotrexate—psoriatic arthritis	0.00018	0.000934	CcSEcCtD
